causal

Pharma Patents Block Competitors by Cost

In pharma, a competitor must find another needle in the haystack and spend as much on R&D as the first discoverer, so an incumbent already in the market can keep rivals out in a way software patents cannot.

causalpending

Speaker

Jerry

Evidence Quote

“So they have to spend as much money on R and D as you did, and you're already in the market, so you can keep them out.”

Source

Why Venture is Hard— Invest Like the Best
Created: 11/20/2026, 2:41:09 AM

Your notes

Loading notes...